Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 May, 2018 03:45 IST
Suven Life Sciences secures 2 overseas product patents
Source: IRIS | 06 Dec, 2017, 10.35AM
Comments  |  Post Comment

Suven Life Sciences announces today that the grant of one product patent from Eurasia and one product patent from Norway corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2034 and 2026 respectively.

The granted claims of the patents include the class of selective 5-HT6 compounds and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.

''We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS arena that are being developed for cognitive disorders with high unmet medical need with huge market potential globally,'' said Venkat Jasti, CEO of Suven. 

Shares of the company gained Rs 8, or 4.2%, to trade at Rs 198.55. The total volume of shares traded was 15,809 at the BSE (10.24 a.m., Wednesday).



Suven Life Sciences Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Infibeam Incorporation to acquire Dubai based Vavian Int'l - 21-May-2018 15:35
Ind-Ra downgrades Reliance Infra and its NCDs to 'BBB+' - 21-May-2018 15:31
UltraTech to acquire demerged cement division of Century Textiles - 21-May-2018 10:38
Thermax to acquire stake of Babcock & Wilcox in JV - 21-May-2018 10:29
L&T Hydrocarbon wins two contracts for fertilizer plants - 21-May-2018 10:24
Banks credit in personal loans too high compared to degrowth in infra sectors: Assocham - 21-May-2018 10:10
Banks credit in personal loans too high compared to degrowth in infra sectors: Assocham - 21-May-2018 10:10
Glenmark Pharma gets nod for Colesevelam HCl tablets - 21-May-2018 10:00
Ashok Leyland quarterly net surges 40% - 18-May-2018 16:38
Bank of Baroda enters into MoU with CCRL - 18-May-2018 16:31
Strides Shasun turns to loss in Jan-Mar quarter - 18-May-2018 15:32
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer